Cargando…
Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy
Nitric oxide (NO), as a gaseous therapeutic agent, shows great potential for the treatment of many kinds of diseases. Although various NO delivery systems have emerged, the immunogenicity and long-term toxicity of artificial carriers hinder the potential clinical translation of these gas therapeutic...
Autores principales: | Huang, Haoyan, Qian, Meng, Liu, Yue, Chen, Shang, Li, Huifang, Han, Zhibo, Han, Zhong-Chao, Chen, Xiang-Mei, Zhao, Qiang, Li, Zongjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541176/ https://www.ncbi.nlm.nih.gov/pubmed/37695201 http://dx.doi.org/10.7554/eLife.84820 |
Ejemplares similares
-
Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection
por: Huang, Anan, et al.
Publicado: (2022) -
Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy
por: Horst, Benjamin G, et al.
Publicado: (2019) -
Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificity
por: Katrekar, Dhruva, et al.
Publicado: (2022) -
Engineering ER-stress dependent non-conventional mRNA splicing
por: Li, Weihan, et al.
Publicado: (2018) -
Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells
por: Stoeber, Miriam, et al.
Publicado: (2020)